| Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome M Labuhn, K Perkins, S Matzk, L Varghese, C Garnett, E Papaemmanuil, ... Cancer cell 36 (2), 123-138. e10, 2019 | 135 | 2019 |
| Senescence-induced oxidative stress causes endothelial dysfunction R Bhayadia, BMW Schmidt, A Melk, M Hömme Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2016 | 131 | 2016 |
| Neutral pH and low–glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis B Schaefer, M Bartosova, S Macher-Goeppinger, P Sallay, P Vörös, ... Kidney international 94 (2), 419-429, 2018 | 94 | 2018 |
| Vascular importance of the miR-212/132 cluster R Kumarswamy, I Volkmann, J Beermann, LC Napp, O Jabs, R Bhayadia, ... European heart journal 35 (45), 3224-3231, 2014 | 89 | 2014 |
| Endogenous tumor suppressor microRNA-193b: therapeutic and prognostic value in acute myeloid leukemia R Bhayadia, K Krowiorz, N Haetscher, R Jammal, S Emmrich, ... Journal of Clinical Oncology 36 (10), 1007-1016, 2018 | 68 | 2018 |
| The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis O Alejo-Valle, K Weigert, R Bhayadia, M Ng, H Issa, C Beyer, S Emmrich, ... Blood, The Journal of the American Society of Hematology 139 (5), 651-665, 2022 | 25 | 2022 |
| The stem cell–specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia S Al-Kershi, R Bhayadia, M Ng, L Verboon, S Emmrich, L Gack, ... Blood advances 3 (24), 4252-4263, 2019 | 25 | 2019 |
| RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemia S Gialesaki, D Bräuer-Hartmann, H Issa, R Bhayadia, O Alejo-Valle, ... Blood 141 (10), 1105-1118, 2023 | 20 | 2023 |
| GATA1s exerts developmental stage-specific effects in human hematopoiesis S Gialesaki, AK Mahnken, L Schmid, M Labuhn, R Bhayadia, D Heckl, ... Haematologica 103 (8), e336, 2018 | 20 | 2018 |
| Preclinical testing of miRNA-193b-3p mimic in acute myeloid leukemias H Issa, R Bhayadia, R Winkler, LE Swart, D Heckl, JH Klusmann Leukemia 37 (7), 1583-1587, 2023 | 13 | 2023 |
| Time-dependent p53 inhibition determines senescence attenuation and long-term outcome after renal ischemia-reperfusion A Baisantry, B Berkenkamp, S Rong, R Bhayadia, I Sörensen-Zender, ... American Journal of Physiology-Renal Physiology 316 (6), F1124-F1132, 2019 | 13 | 2019 |
| CRISPR/Cas9 gene editing of immune checkpoint receptor NKG2A improves the efficacy of primary CD33-CAR-NK cells against AML N Albinger, T Bexte, L Buchinger, P Wendel, A Al-Ajami, A Gessner, ... Blood 140 (Supplement 1), 4558-4559, 2022 | 12 | 2022 |
| Renal phenotype of young and old telomerase-deficient mice C Schildhorn, C Jacobi, A Weissbrodt, C Hermstedt, JH Westhoff, ... Mechanisms of Ageing and Development 150, 65-73, 2015 | 10 | 2015 |
| Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core J Grimm, R Bhayadia, L Gack, D Heckl, JH Klusmann Leukemia 36 (7), 1926-1930, 2022 | 8 | 2022 |
| Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15 M Ng, L Verboon, H Issa, R Bhayadia, MW Vermunt, R Winkler, L Schüler, ... Iscience 26 (10), 2023 | 3 | 2023 |
| MiR-193a is a negative regulator of hematopoietic stem cells and promotes anti-leukemic effects in acute myeloid leukemia K Krowiorz, R Bhayadia, R Jammal, C Pabst, N Pochert, C Rueß, C Miller, ... Blood 132, 2627, 2018 | 3 | 2018 |
| PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia I Alshamleh, N Kurrle, P Makowka, R Bhayadia, R Kumar, S Süsser, ... Leukemia 37 (12), 2367-2382, 2023 | 2 | 2023 |
| RUNX1 isoform disequilibrium in the development of trisomy 21 associated myeloid leukemia S Gialesaki, D Bräuer-Hartmann, R Bhayadia, O Alejo-Valle, H Issa, ... bioRxiv, 2022.03. 07.483334, 2022 | 2 | 2022 |
| P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS. N Albinger, T Bexte, A Al-Ajami, P Wendel, L Buchinger, A Gessner, ... HemaSphere 7 (S3), e71265f8, 2023 | 1 | 2023 |
| Myeloid leukemia vulnerabilities at CTCF-enriched long noncoding RNA loci M Ng, L Verboon, H Issa, R Bhayadia, O Alejo-Valle, D Borchert, ... | 1 | 2021 |
Jan-Henning KlusmannGoethe University FrankfurtDirección de correo verificada de em.uni-frankfurt.de
